Constellation Brands (STZ) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Dec, 2025Executive summary
Achieved enterprise net sales growth of 2% to $10.2B in FY25, with substantial comparable operating margin and double-digit comparable EPS growth, despite softer consumer demand due to non-structural socioeconomic factors.
Attained #1 growth leader status among large CPG companies, driven by high-end beer and premium wine/spirits portfolio.
Completed significant portfolio reshaping, including SVEDKA and 2025 Wine Divestitures, and restructuring actions expected to generate over $200M in annualized cost savings by FY28.
Returned nearly $1.9B to shareholders in FY25, including $1.1B in share repurchases and $732M in dividends.
Maintained disciplined capital allocation and strong brand health, with significant share gains and continued consumer loyalty, especially among Hispanic consumers.
Financial highlights
FY25 net sales rose 2% to $10.2B; comparable operating income grew 7% to $3.5B; comparable EPS increased 11% to $13.78.
Beer segment net sales up 5% to $8.54B; operating income up 10% to $3.39B; operating margin increased 180 bps to 39.7%.
Wine & Spirits net sales declined 7% to $1.67B; operating income down 18% to $325M, reflecting divestitures.
FY25 reported net loss attributable to CBI of $81M due to non-cash impairments and divestiture impacts; reported EPS $(0.45) due to $3.3B non-cash impairment.
Operating cash flow $3.2B (up 13%); free cash flow $1.94B (up 28%).
Outlook and guidance
FY26–FY28: Enterprise net sales expected to grow at low single-digit CAGR; operating margin ~34–35%.
Beer net sales growth guidance: 0–3% for FY26, 2–4% for FY27–FY28; operating margins expected at 39–40% for FY27–FY28.
Wine & Spirits segment to deliver up to 3% net sales growth and 22–24% operating margins post-divestiture.
Cumulative operating cash flow of ~$9B and free cash flow of $6–7B expected from FY26–FY28.
Guidance incorporates U.S. and Canadian tariffs, with no material macroeconomic improvement expected; some marginal improvement possible in 2026.
Latest events from Constellation Brands
- Q1 net sales up 6% to $2.7B, beer growth drives margin gains; FY25 outlook raised.STZ
Q1 20253 Feb 2026 - Double-digit EPS growth maintained despite lower top-line guidance, driven by cost savings.STZ
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - $2.25B goodwill impairment in Wine & Spirits drove a net loss despite strong Beer growth.STZ
Q2 202519 Jan 2026 - Distribution, innovation, and premiumization drive growth amid evolving market conditions.STZ
Morgan Stanley Global Consumer & Retail Conference12 Jan 2026 - Beer growth offsets Wine and Spirits decline as $2.25B impairment impacts outlook.STZ
Q3 202510 Jan 2026 - Q3 FY26 net sales dropped 10%, but Beer margins rose and cash flow guidance held firm.STZ
Q3 20268 Jan 2026 - Board recommends against ESG shareholder proposals, highlights strong FY2024 results and governance.STZ
Proxy Filing1 Dec 2025 - Record sales, board refreshment, and strong shareholder returns highlight this year's proxy.STZ
Proxy Filing1 Dec 2025 - Annual meeting covers director elections, auditor ratification, and key ESG proposals.STZ
Proxy Filing1 Dec 2025